Psoriatic Arthritis Market by Mechanism of Action and Type of Disease- Global Industry Analysis and Forecast to 2023

2018-05-30 / 3800.00 / Pharma & Healthcare / 105 Pages

Description

Industry Outlook and Trend Analysis

The Psoriatic Arthritis Market has observed substantial development in the recent years and is foreseen to develop significantly in the upcoming years. Psoriatic arthritis is a constant inflammatory disease that influences the distal joints in the body and may likewise influence the back and sacroiliac joints of the pelvis. The worldwide market for psoriatic arthritis is foreseen to witness direct development amid the estimate time frame and factors like the expansion in entrance of biologic treatments are required to enlarge the prospects for development in this market. Furthermore, the current launch of products like Otezla and Stelara is additionally anticipated that would help market development amid the estimate time frame.

Mechanism of Action Outlook and Trend Analysis

The TNF inhibitors assist in suppressing the inflammatory reaction in the patient's body. These inhibitors are used to monitor diseases like rheumatoid arthritis, psoriasis, psoriatic arthritis, seronegative spondyloarthropathies, and inflammatory bowel disease. Besides, its capacity to make use of a focused on system to treat the vast majority of the incendiary and immune system illnesses is essentially in charge of its high share of the market.

Type of Disease outlook ad Trend Analysis

The mild psoriatic arthritis section represents over 60% of all the analysed cases and is the most well-known kind of psoriatic arthritis in patients over the globe. This condition influences under four joints in the body and is otherwise called oligoarticular arthritis.

Regional Outlook and Trend Analysis

Geographically, the worldwide psoriatic arthritis market is sectioned into five expansive districts viz. Latin America, North America, Europe, Asia-Pacific, and the Middle East and Africa. North America is evaluated to lead the worldwide psoriatic arthritis market. Europe market is likewise anticipated to encounter high development soon.

Competitive Insights

This market is essentially ruled by leading players because of their broad item portfolios. The organization that fabricates and markets a medication that can treat psoriatic arthritis, and furthermore show a high wellbeing and adequacy profile, is foreseen to develop over its adversaries amid the estimate time frame. The leading players in the market are Janssen Pharmaceutica NV, AbbVie Inc, Pfizer, Bristol-Myers Squibb, Biogen, Sun Pharmaceutical Industries Ltd, Celgene and Eli Lilly And Company.

The Psoriatic Arthritis market is segmented as follwos-

By Mechanism of Action:


Interleukin blockers
TNF inhibitors
PDE4 inhibitors
Others


By Type of Disease:


Moderate psoriatic arthritis
Severe psoriatic arthritis
Mild psoriatic arthritis


By Region


North America



U.S
Canada
Mexico



Europe



Germany
France
UK
Italy
Spain
Rest of Europe



Asia-Pacific



Japan
China
Australia
India
South Korea
Rest of Asia Pacific



Rest of the World



Brazil
South Africa
Saudi Arabia
United Arab Emirates
Others


Some of the key questions answered by the report are:


What was the market size in 2014 and forecast from 2015 to 2023`
What will be the industry market growth from 2015 to 2023`
What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast`
What are the major segments leading the market growth and why`
Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition`

Table of Content

Table of Contents
1. Introduction
1.1. Report Description
1.2. Research Methodology
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Expansion in entrance of biologic treatments
3.2.3. Restraints
3.2.4. Opportunities
3.2.4.1. Emerging Markets to Offer Lucrative Growth Opportunities
4. Psoriatic Arthritis Market, By Mechanism Of Action
4.1. Introduction
4.2. Global Psoriatic Arthritis Sales, Revenue and Market Share by Mechanism Of Action(2014-2017)
4.2.1. Global Psoriatic Arthritis Sales and Sales Share by Mechanism Of Action(2014-2017)
4.2.2. Global Psoriatic Arthritis Revenue and Revenue Share by Mechanism Of Action(2014-2017)
4.3. Psoriatic Arthritis Market Assessment and Forecast, By Mechanism of Action, 2014-2023
4.4. Interleukin blockers
4.4.1. Market Assessment and Forecast, By Region, 2014-2023($Million)
4.5. TNF inhibitors
4.5.1. Market Assessment and Forecast, By Region, 2014-2023($Million)
4.6. PDE4 inhibitors
4.6.1. Market Assessment and Forecast, By Region, 2014-2023($Million)
4.7. Others
4.7.1. Market Assessment and Forecast, By Region, 2014-2023($Million)
5. Psoriatic Arthritis Market, By Type of disease
5.1. Introduction
5.2. Global Psoriatic Arthritis Sales, Revenue and Market Share by Type of disease (2014-2017)
5.2.1. Global Psoriatic Arthritis Sales and Sales Share by Type of disease (2014-2017)
5.2.2. Global Psoriatic Arthritis Revenue and Revenue Share by Type of disease (2014-2017)
5.3. The Psoriatic Arthritis Market Assessment and Forecast, By Type of disease, 2014-2023
5.4. Moderate psoriatic arthritis
5.4.1. Market Assessment and Forecast, By Region, 2014-2023($Million)
5.5. Severe psoriatic arthritis
5.5.1. Market Assessment and Forecast, By Region, 2014-2023($Million)
5.6. Mild psoriatic arthritis
5.6.1. Market Assessment and Forecast, By Region, 2014-2023($Million)
6. Psoriatic Arthritis Market, By Region
6.1. Introduction
6.2. Psoriatic Arthritis Market Assessment and Forecast, By Region, 2014-2023 ($Million)
6.3. Global Psoriatic Arthritis Sales, Revenue and Market Share by Regions
6.3.1. Global Psoriatic Arthritis Sales by Regions (2014-2017)
6.3.2. Global Psoriatic Arthritis Revenue by Regions (2014-2017)
6.4. North America
6.4.1. North America Psoriatic Arthritis Sales and Growth Rate (2014-2017)
6.4.2. Market Assessment and Forecast, By Country, 2014-2023($Million)
6.4.3. Market Assessment and Forecast, By Mechanism of Action, 2014-2023($Million)
6.4.4. Market Assessment and Forecast, By Type of disease, 2014-2023($Million)
6.4.5. U.S.
6.4.5.1. Market Assessment and Forecast, By Mechanism of Action, 2014-2023($Million)
6.4.5.2. Market Assessment and Forecast, By Type of disease, 2014-2023($Million)
6.4.6. Canada
6.4.6.1. Market Assessment and Forecast, By Mechanism of Action, 2014-2023($Million)
6.4.6.2. Market Assessment and Forecast, By Type of disease, 2014-2023($Million)
6.4.7. Mexico
6.4.7.1. Market Assessment and Forecast, By Mechanism of Action, 2014-2023($Million)
6.4.7.2. Market Assessment and Forecast, By Type of disease, 2014-2023($Million)
6.5. Europe
6.5.1. Europe Psoriatic Arthritis Sales and Growth Rate (2014-2017)
6.5.2. Market Assessment and Forecast, By Country, 2014-2023($Million)
6.5.3. Market Assessment and Forecast, By Mechanism of Action, 2014-2023($Million)
6.5.4. Market Assessment and Forecast, By Type of disease, 2014-2023($Million)
6.5.5. Germany
6.5.5.1. Market Assessment and Forecast, By Mechanism of Action, 2014-2023($Million)
6.5.5.2. Market Assessment and Forecast, By Type of disease, 2014-2023($Million)
6.5.6. France
6.5.6.1. Market Assessment and Forecast, By Mechanism of Action, 2014-2023($Million)
6.5.6.2. Market Assessment and Forecast, By Type of disease, 2014-2023($Million)
6.5.7. UK
6.5.7.1. Market Assessment and Forecast, By Mechanism of Action, 2014-2023($Million)
6.5.7.2. Market Assessment and Forecast, By Type of disease, 2014-2023($Million)
6.5.8. Italy
6.5.8.1. Market Assessment and Forecast, By Mechanism of Action, 2014-2023($Million)
6.5.8.2. Market Assessment and Forecast, By Type of disease, 2014-2023($Million)
6.5.9. Spain
6.5.9.1. Market Assessment and Forecast, By Mechanism of Action, 2014-2023($Million)
6.5.9.2. Market Assessment and Forecast, By Type of disease, 2014-2023($Million)
6.5.10. Rest of Europe
6.5.10.1. Market Assessment and Forecast, By Mechanism of Action, 2014-2023($Million)
6.5.10.2. Market Assessment and Forecast, By Type of disease, 2014-2023($Million)
6.6. Asia-Pacific
6.6.1. Asia-Pacific Psoriatic Arthritis Sales and Growth Rate (2014-2017)
6.6.2. Market Assessment and Forecast, By Country, 2014-2023($Million)
6.6.3. Market Assessment and Forecast, By Mechanism of Action, 2014-2023($Million)
6.6.4. Market Assessment and Forecast, By Type of disease, 2014-2023($Million)
6.6.5. Japan
6.6.5.1. Market Assessment and Forecast, By Mechanism of Action, 2014-2023($Million)
6.6.5.2. Market Assessment and Forecast, By Type of disease, 2014-2023($Million)
6.6.6. China
6.6.6.1. Market Assessment and Forecast, By Mechanism of Action, 2014-2023($Million)
6.6.6.2. Market Assessment and Forecast, By Type of disease, 2014-2023($Million)
6.6.7. Australia
6.6.7.1. Market Assessment and Forecast, By Mechanism of Action, 2014-2023($Million)
6.6.7.2. Market Assessment and Forecast, By Type of disease, 2014-2023($Million)
6.6.8. India
6.6.8.1. Market Assessment and Forecast, By Mechanism of Action, 2014-2023($Million)
6.6.8.2. Market Assessment and Forecast, By Type of disease, 2014-2023($Million)
6.6.9. South Korea
6.6.9.1. Market Assessment and Forecast, By Mechanism of Action, 2014-2023($Million)
6.6.9.2. Market Assessment and Forecast, By Type of disease, 2014-2023($Million)
6.6.10. Rest of Asia-Pacific
6.6.10.1. Market Assessment and Forecast, By Mechanism of Action, 2014-2023($Million)
6.6.10.2. Market Assessment and Forecast, By Type of disease, 2014-2023($Million)
6.7. Rest of the World
6.7.1. Rest of the World Psoriatic Arthritis Sales and Growth Rate (2014-2017)
6.7.2. Market Assessment and Forecast, By Country, 2014-2023($Million)
6.7.3. Market Assessment and Forecast, By Mechanism of Action, 2014-2023($Million)
6.7.4. Market Assessment and Forecast, By Type of disease, 2014-2023($Million)
6.7.5. Brazil
6.7.5.1. Market Assessment and Forecast, By Mechanism of Action, 2014-2023($Million)
6.7.5.2. Market Assessment and Forecast, By Type of disease, 2014-2023($Million)
6.7.6. Turkey
6.7.6.1. Market Assessment and Forecast, By Mechanism of Action, 2014-2023($Million)
6.7.6.2. Market Assessment and Forecast, By Type of disease, 2014-2023($Million)
6.7.7. Saudi Arabia
6.7.7.1. Market Assessment and Forecast, By Mechanism of Action, 2014-2023($Million)
6.7.7.2. Market Assessment and Forecast, By Type of disease, 2014-2023($Million)
6.7.8. South Africa
6.7.8.1. Market Assessment and Forecast, By Mechanism of Action, 2014-2023($Million)
6.7.8.2. Market Assessment and Forecast, By Type of disease, 2014-2023($Million)
6.7.9. United Arab Emirates
6.7.9.1. Market Assessment and Forecast, By Mechanism of Action, 2014-2023($Million)
6.7.9.2. Market Assessment and Forecast, By Type of disease, 2014-2023($Million)
6.7.10. Others
6.7.10.1. Market Assessment and Forecast, By Mechanism of Action, 2014-2023($Million)
6.7.10.2. Market Assessment and Forecast, By Type of disease, 2014-2023($Million)
7. Company Profiles
7.1. Janssen Pharmaceutica NV
7.1.1. Business Overview
7.1.2. Product Portfolio
7.1.3. Strategic Developments
7.1.4. Psoriatic Arthritis Sales, Revenue and Market Share
7.2. AbbVie Inc
7.2.1. Business Overview
7.2.2. Product Portfolio
7.2.3. Strategic Developments
7.2.4. Psoriatic Arthritis Sales, Revenue and Market Share
7.3. Pfizer
7.3.1. Business Overview
7.3.2. Product Portfolio
7.3.3. Strategic Developments
7.3.4. Psoriatic Arthritis Sales, Revenue and Market Share
7.4. Bristol-Myers Squibb
7.4.1. Business Overview
7.4.2. Product Portfolio
7.4.3. Strategic Developments
7.4.4. Psoriatic Arthritis Sales, Revenue and Market Share
7.5. Biogen
7.5.1. Business Overview
7.5.2. Product Portfolio
7.5.3. Strategic Developments
7.5.4. Psoriatic Arthritis Sales, Revenue and Market Share
7.6. Sun Pharmaceutical Industries Ltd
7.6.1. Business Overview
7.6.2. Product Portfolio
7.6.3. Strategic Developments
7.6.4. Psoriatic Arthritis Sales, Revenue and Market Share
7.7. Celgene
7.7.1. Business Overview
7.7.2. Product Portfolio
7.7.3. Strategic Developments
7.7.4. Psoriatic Arthritis Sales, Revenue and Market Share
7.8. Eli Lilly And Company
7.8.1. Business Overview
7.8.2. Product Portfolio
7.8.3. Strategic Developments
7.8.4. Psoriatic Arthritis Sales, Revenue and Market Share
8. Global Psoriatic Arthritis Market Competition, by Manufacturer
8.1. Global Psoriatic Arthritis Sales and Market Share by Manufacturer (2016-2017)
8.2. Global Psoriatic Arthritis Revenue and Market Share by Manufacturer (2016-2017)
8.3. Top 5 Psoriatic Arthritis Manufacturer Market Share
8.4. Market Competition Trend
List of Tables and Figures
*You can glance through the list of Tables and Figures when you view the sample copy of Psoriatic Arthritis Market.


Table of Figures

*You can glance through the list of Tables and Figures when you view the sample copy of Biomass Energy Market.

Request Sample

* mark fields are compulsory